TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Instagram Outage Disrupts Thousands of U.S. Users 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
FORT MYERS, Fla., Aug. 31, 2016 -- 21st Century Oncology Holdings, Inc., the largest global, physician led provider of integrated cancer care services, today announced that it has rescheduled its conference call to discuss financial results for the fourth quarter and year ended December 31, 2015 and restated financial statements for prior periods. The conference call has been rescheduled to Tuesday, September 6, 2016 at 3:00 p.m. Eastern Time. The conference call and replay of the conference call may be accessed as follows:
Dial-in numbers: 877-407-9039 (Domestic); 201-689-8470 (International)
Replay Dial-in Numbers (Available until September 20, 2016): 877-870-5176 (Domestic); 858-384-5517 (International); Replay Pin Number: 13644461
A live webcast and webcast replay of the call will also be available from the Events section of the corporate web site at www.21co.com.
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of December 31, 2015, the Company operated 181 treatment centers, including 145 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]
